glp 1 drugs pills Ro Launches Wegovy® Pill Through Integration with Novo Nordisk This gentle GLP-1 pills are on the

Description

GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy THURSDAY, July 16, 2026 -- Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a higher risk for ischemic optic neuropathy (ION) compared with

The most well-known GLP-1 receptor agonists include semaglutide (sold as Ozempic for diabetes and Wegovy for weight loss), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon)

GLP-1 receptor agonists do not affect sodium intake: Exploratory analyses from two randomized clinical trials

GLP-1 RAs are currently being investigated for various new areas, such as cardiovascular diseases, non-alcoholic steatohepatitis (NASH), Alzheimers disease, and chronic kidney disease